首页> 外文期刊>ClinicoEconomics and Outcomes Research >Healthcare Resource Utilization Pre- and Post-Initiation of Eslicarbazepine Acetate Among Pediatric Patients with Focal Seizure: Evidence from Routine Clinical Practice
【24h】

Healthcare Resource Utilization Pre- and Post-Initiation of Eslicarbazepine Acetate Among Pediatric Patients with Focal Seizure: Evidence from Routine Clinical Practice

机译:医疗资源利用综合癫痫发作的儿科患者醋酸甲酸母碱醋酸乳碱的发酵后期:来自常规临床实践的证据

获取原文
           

摘要

Objective: To examine the impact of initiating treatment with eslicarbazepine acetate (ESL) on healthcare resource utilization (HCRU) among pediatric patients with focal seizures (FS). Methods: This retrospective study used Symphony Health’s Integrated Dataverse? claims data. Patients aged 4 to 17 years with a diagnosis of FS and a new prescription for ESL between April 2015 and June 2018 were included and defined as the overall patient population. Index date was the first dispensed claim for ESL. Baseline period was the 90-day block immediately prior to the index date. The follow-up period comprised up to 4 consecutive 90-day blocks immediately following the index date. Subgroups were defined based on the presence (DP ) or absence (DP?) of developmental and/or psychiatric disorders at baseline. All-cause and FS-related inpatient (IP), emergency room (ER), outpatient (OP) hospital, and office (OF) visits were measured during the follow-up period. Reduction in HCRU per block in the post-ESL period was assessed using fixed-effects linear regression models. Results: A total of 234 patients were included in the overall study population, of whom 86 (36.8%) were DP and 148 (63.2%) were DP?. Relative to the baseline period, significant reductions were observed in the overall population for all-cause ER ( P =0.001), OP ( P 0.001), and OF (P 0.001) visits and FS-related IP ( P =0.037) and OF ( P 0.001) visits in the follow-up period. Among DP and DP? patients, significant reductions were observed for all-cause ER (DP : P =0.024; DP?: P =0.017), OP (DP : P 0.001; DP?: P =0.035), and OF (DP : P =0.004; DP?: P =0.001) visits during the follow-up period. No significant differences were observed between DP and DP? patients in the change in all-cause or FS-related HCRU from baseline to the follow-up period. Conclusion: Pediatric patients with FS (DP and DP-) who initiated ESL had significant reductions in all-cause ER, OP, and OF visits and FS-related IP and OF visits.
机译:目的:探讨在局灶性癫痫发作(FS)中儿科患者对母乳杀螨脂肽(ESL)对母乳杀螨剂(ESL)的影响。方法:这项回顾性研究使用了交响乐健康的集成Dativere?声明数据。在2015年4月至2018年4月至2018年4月至6月诊断为FS和ESL的新处方年龄4至17岁的患者被包括并定义为整体患者人口。索引日期是ESL的首次分配索赔。基线期间是指数日期之前的90天块。随访期间,在索引日期之后,立即包含连续4个90天的块。基于基线的发育和/或精神病疾病的存在(DP)或缺席(DP)或缺失(DP)来定义亚组。在随访期间,测量了所有原因和FS相关的住院病人(IP),急诊室(ER),门诊(OP)医院和办公室(OF)。使用固定效应线性回归模型评估ESL期间每块每块的HCRU的减少。结果:总研究人群共有234名患者,其中86例(36.8%)为DP,148名(63.2%)是DP?相对于基线期间,在全归根ER(P = 0.001),OP(P <0.001)的总体群体中观察到显着降低,以及(P <0.001)访问和FS相关IP(P = 0.037) (p <0.001)在随访期间访问。在DP和DP中?患者的所有原因ER(DP:P = 0.024; DP?:P = 0.017),OP(DP:P <0.001; DP?:P = 0.035),以及(DP:P = 0.004 ; dp?:p = 0.001)在后续期间访问。 DP和DP之间没有观察到显着差异?患者在所有原因或FS相关的HCRU的变化中,从基线到后续期间。结论:发起ESL的FS(DP和DP-)的​​儿科患者在所有原因ER,OP和访问和相关IP和访问中都有重大减少。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号